These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 7892601)

  • 21. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
    Kaur G; Gazit A; Levitzki A; Stowe E; Cooney DA; Sausville EA
    Anticancer Drugs; 1994 Apr; 5(2):213-22. PubMed ID: 8049505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
    Mishra S; Mathur R; Hamburger AW
    Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.
    Hoffman R; Dennis IF; Donaldson J
    Cancer Chemother Pharmacol; 1995; 36(4):316-24. PubMed ID: 7628051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tyrosine kinase inhibitors on beta-cell proliferation.
    Burns CJ; Howell SL; Persaud SJ
    Biochem Soc Trans; 1997 Feb; 25(1):117S. PubMed ID: 9057015
    [No Abstract]   [Full Text] [Related]  

  • 25. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors.
    Yang SG; Saifeddine M; Laniyonu A; Hollenberg MD
    J Pharmacol Exp Ther; 1993 Feb; 264(2):958-66. PubMed ID: 8437135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor.
    Ohmichi M; Pang L; Ribon V; Gazit A; Levitzki A; Saltiel AR
    Biochemistry; 1993 May; 32(17):4650-8. PubMed ID: 7683492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins.
    Párrizas M; Gazit A; Levitzki A; Wertheimer E; LeRoith D
    Endocrinology; 1997 Apr; 138(4):1427-33. PubMed ID: 9075698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
    Agbotounou WK; Levitzki A; Jacquemin-Sablon A; Pierre J
    Mol Pharmacol; 1994 May; 45(5):922-31. PubMed ID: 7514714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine kinase activity is necessary for growth factor-stimulated rabbit type II pneumocyte proliferation.
    Chess PR; Ryan RM; Finkelstein JN
    Pediatr Res; 1994 Oct; 36(4):481-6. PubMed ID: 7529394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor-specific protein tyrosine phosphorylation in preimplantation embryo development.
    Paria BC; Tsukamura H; Dey SK
    Biol Reprod; 1991 Nov; 45(5):711-8. PubMed ID: 1721842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
    Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
    J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells.
    Wijetunge S; Aalkjaer C; Schachter M; Hughes AD
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1620-3. PubMed ID: 1336377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of domestic cat spermatozoa acrosome reaction and zona pellucida penetration by tyrosine kinase inhibitors.
    Pukazhenthi BS; Wildt DE; Ottinger MA; Howard J
    Mol Reprod Dev; 1998 Jan; 49(1):48-57. PubMed ID: 9406195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrphostins suppress the growth of psoriatic keratinocytes.
    Ben-Bassat H; Vardi DV; Gazit A; Klaus SN; Chaouat M; Hartzstark Z; Levitzki A
    Exp Dermatol; 1995 Apr; 4(2):82-8. PubMed ID: 7640880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor.
    Meydan N; Grunberger T; Dadi H; Shahar M; Arpaia E; Lapidot Z; Leeder JS; Freedman M; Cohen A; Gazit A; Levitzki A; Roifman CM
    Nature; 1996 Feb; 379(6566):645-8. PubMed ID: 8628398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action.
    Aflalo E; Iftach S; Segal S; Gazit A; Priel E
    Cancer Res; 1994 Oct; 54(19):5138-42. PubMed ID: 7923131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle.
    Di Salvo J; Steusloff A; Semenchuk L; Satoh S; Kolquist K; Pfitzer G
    Biochem Biophys Res Commun; 1993 Feb; 190(3):968-74. PubMed ID: 8439345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of mouse gamete interaction by a sperm tyrosine kinase.
    Leyton L; LeGuen P; Bunch D; Saling PM
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11692-5. PubMed ID: 1281543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein tyrosine kinase inhibitors as novel therapeutic agents.
    Levitzki A
    Pharmacol Ther; 1999; 82(2-3):231-9. PubMed ID: 10454200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.